By identifying those HIV-infected individuals at risk for ART failures, such as those with thrombocytopenia, alcohol abuse, and with BDNF and serotonin deficits the study may permit early clinical follow-ups and interventions. The gene discussed is BDNF; the disease is Thrombocytopenia.